Microbiotica, Genentech in microbiome deal

Genentech Inc. partnered with Microbiotica Ltd. (Cambridge, U.K.) to discover targets and therapeutics for inflammatory bowel disease (IBD) using Microbiotica’s precision metagenomics microbiome

Read the full 236 word article

User Sign In